ArticleFrontiers in pharmacology2025

HRS-4642 combined with nimotuzumab in the treatment of recurrent or metastatic pancreatic ductal adenocarcinoma: study protocol of a single-arm, prospective phase Ib/II trial.

Qingqing Leng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.